Background. The isolation of asymptomatic Clostridium difficile (CD) carriers may decrease the incidence of hospital-associated C. difficile infections (CDI), but its impact on isolation precaution needs is unknown.
Clostridium difficile infection (CDI) is a disease caused by anaerobic gram-positive bacteria, with clinical manifestations ranging from mild watery diarrhea to fulminant colitis and toxic megacolon [1] . This infection has become a major public health concern due to the emergence of highly virulent strains such as the NAP1/BI/027 strain in the early 2000s [2, 3] . It is estimated that >400 000 episodes of CDI occur every year in the United States, causing 29 000 deaths and generating $ 4.8 billion in excess medical expenditures [4] [5] [6] .
Current infection control recommendations focus mainly on limiting the spread of the organism from symptomatic patients with CDI [7, 8] . According to current guidelines, patients with active CDI should be placed under contact isolation precautions (a set of infection control measures that includes, among others, the use of gloves and gowns when caring for infected individuals) in private rooms [7, 8] . However, isolation precautions are currently not recommended for asymptomatic C. difficile carriers (CD carriers) [7, 8] , even though some studies suggest that these asymptomatic patients may also play an important role in the transmission of C. difficile [9] [10] [11] [12] . CD carriers may harbor C. difficile on their skin and may shed the organism in their surrounding environment and contaminate healthcare workers' hands [13, 14] . These asymptomatic carriers could be linked to up to 30%-79% of hospital-acquired CDI [15] .
Our team previously reported the results of a study suggesting that the detection and isolation of CD carriers upon hospital admission could significantly decrease the incidence of hospital-associated CDI (HA-CDI) [16] . In this single-center study, this strategy led to a >60% decrease in HA-CDI incidence over a 15-month period [16] . However, this strategy inevitably led to the application of isolation precautions for numerous CD carriers for their entire hospital stay [16] . The additional resources required to isolate these carriers have led some experts to question the feasibility of such infection control strategy [15, 17, 18] . The impact of isolating CD carriers on the overall burden of isolation precautions required to control the transmission of C. difficile remains unknown. On one hand, isolating CD carriers would M A J O R A R T I C L E increase the isolation precaution burden. On the other hand, the decrease in CDI incidence over the long term is expected to reduce the number isolation-days required for patients with CDI. We performed a time series analysis to better understand the overall impact of this novel infection control strategy on the isolation burden related to C. difficile.
METHODS

Study Design and Setting
The Quebec Heart and Lung Institute (QHLI) is a 354-bed tertiary institution that implemented a CD carrier isolation program in November 2013 [16] . We conducted a retrospective time series analysis to evaluate the immediate and long-term effects of the intervention on the isolation precaution burden. Surveillance was conducted prospectively by infection control practitioners. The study population included all patients admitted between 1 April 2008 and 11 August 2016. Data were aggregated into 4-week periods (13 periods per year). The time series was divided into 3 distinct study periods to take into account changes in C. difficile infection control policies: (1) Between April 2008 and March 2011, patients with CDI were isolated until 72 hours after symptom resolution only; (2) between April 2011 and November 2013, patients with CDI were isolated until hospital discharge in an attempt to control persistently high CDI incidence rates; and (3) between November 2013 and August 2016, patients with CDI as well as CD carriers were isolated until hospital discharge [16] .
Definitions
CDIs were defined as per the Quebec surveillance protocol as either (1) diarrhea (≥3 unformed or liquid stools in <24 hours) lasting ≥24 hours without any other known etiology combined with a positive assay for toxigenic C. difficile or a positive polymerase chain reaction (PCR) result for tcdB gene; (2) visualization of pseudomembranes by colonoscopy; or (3) a histopathologic diagnosis [19] . CD carriers were defined as patients with positive screening test on admission but without any diarrhea. A patient-day was defined as a 24-hour period during which a single patient is admitted. An isolation-day (either for CD carriage or CDI) was defined as a 24-hour period during which a single patient is placed under contact isolation precautions. Total C. difficile isolation-days were defined as the sum of the isolation-days for patients with CDI and CD carriers. CD carriers who progressed to CDI were placed under CDI isolation precautions on the day of diagnosis, and subsequent isolation-days were counted as isolation-days for CDI. Monthly prevalence was computed as the total number of isolation-days divided by the total number of patient-days per 4-week period.
Intervention and CDI Control Measures
The full description of the CD carrier screening and detection protocol has been described previously [16] . In brief, patients admitted through the emergency department were screened for C. difficile carriage via a rectal swab and tested for the presence of tcdB using PCR (BD GeneOhm Cdiff, Franklin Lakes, New Jersey) [16] . Identified CD carriers were placed under infection control measures resembling those for CDI but modified to minimize the impact on bed management and workflow [16] . For example, healthcare workers were not required to wear isolation gowns, and CD carriers could share a room with noncarriers with the privacy curtains drawn [16] .
Outcomes
The overall prevalence of total C. difficile isolation-days during each study period and the changes in prevalence and trend in total C. difficile isolation-days following changes in infection control strategies were selected as the main outcomes for this study. Changes in the prevalence of isolation-days for CDI and CD carriage during the intervention were considered secondary outcomes. As the reduction in isolation-days associated with averted CDI cases was not expected to occur immediately after the implementation of the CD carrier isolation program, we also quantified the short-term and long-term impact of this isolation policy by investigating the average prevalence of isolation-days for C. difficile for the first and last 12 months of this intervention period.
Statistical Analysis
Isolation-days for CDI and CD carriage were extracted from the Infection Control Service database. First, prevalence of isolation-days was compared for each study period by using the Z test of the difference of native logarithm of prevalence of isolation-days. In a second step, we used segmented regression of interrupted time series data to assess the impact of the each infection control strategy on isolation-days through the change in level and the change in trend, respectively, by creating indicator variables as described previously [16] . We also investigated the trend in the number of isolation-days for CDI and CD carriers during the second and third intervention periods by calculating a rate ratio (RR) and corresponding 95% confidence intervals (CIs). Comparisons between incidence rates were performed using Z test of the difference of native logarithm of incidence rate. SAS software version 9.2 (SAS Institute, Cary, North Carolina) was used for all analyses. A P value of <.05 was considered statistically significant.
Ethical and Methodological Considerations
The institutional research ethics committee approved the extraction of data for analysis and publication. Only aggregated, anonymized data collected as per Accreditation Canada requirements were extracted. This report follows the ORION statement for the reporting of nosocomial infection intervention studies [20] . 
. difficile were lowest during period 1, when CDI patients were only isolated until symptom resolution (average, 12.9 isolation-days per 1000 patient-days). The overall prevalence of isolation-days during period 2 (isolation of patients with CDI until discharge) was higher (average, 26.2 isolation-days per 1000 patient-days). The highest average prevalence was seen in period 3, during which CD carriers and CDI patients were both isolated until discharge (average, 37.8/1000 patient-days). A summary of aggregate data for each period can be found in Table 1 .
Changes in Prevalence and Trend
The levels and trends in isolation-days throughout the study period are indicated in Table 2 and illustrated in Figure 1 . During period 1, the trend of the prevalence of isolation-days remained relatively constant (RR per 4-week period, 1.005; P = .20). Once isolation precautions were extended to include all patients with CDI until their hospital discharge (period 2), an immediate 46% increase in prevalence of isolation-days was seen (RR = 1.456, P < .001). Isolation-day prevalence increased significantly during period 2 (RR per 4-week period, 1.012; 95% CI, 1.003-1.020; P = .006). However, this upward trend was not significantly different from the trend during period 1 (change in trend, 1.007; P = 0.19). Upon implementation of the screening and isolation policy for CD carriers in period 3, there was another 66% immediate increase in the prevalence of total isolation-days for CD (RR, 1.662; P < .001). Following this sudden increase, the prevalence decreased significantly throughout period 3 at a rate of approximately 3% per month (RR per 4-week period, 0.970; P < .001). Consequently, the monthly prevalence was significantly higher during the first 12 months compared to the last 12 months of that period (46.3 vs 30.6 per 1000 patient-days, P < .001; Figure 1) . Hence, the prevalence of total CD isolation-days during the last 12 months of period 3 was 17% higher than the overall prevalence seen during period 2 (30.6 vs 26.2 isolation-days per 1000 patientdays, respectively, P < .001).
Most of the decrease seen during period 3 was due to a decrease in the number of isolation-days for patients with CDI (RR per 4-week period, 0.944; P < .001). By contrast, the prevalence of isolation-days for CD carriers remained stable throughout period 3 (RR, 0.996; P = .21). Consequently, the ratio of isolation precautions for CD carriage vs CDI increased from approximately 1:1 during the first 12 months of the intervention to 3:1 during the last 12 months.
DISCUSSION
Even though various clinical and modeling studies suggest that the incidence of HA-CDI could be decreased by detecting and isolating CD carriers [11, 16, 21] , some experts have raised concern regarding the widespread applicability of such strategy, and questioned the impact it could have on the isolation burden [7, 18] . The current study indicates that following an initial 66% increase in the prevalence of isolation-days, the long-term burden of a CD carrier isolation policy was only 17% higher than a policy in which CD carriers are not isolated, but in which patients with CDI are hospitalized until discharge (absolute difference of <5 per 1000 patient-days). This indicates that, in our center, the decrease in the incidence of CDI over the long term compensated to a great extent for the increased isolation burden of CD carriers. On the other hand, the magnitude of the increase is greater when this novel infection control strategy is compared with a policy of isolating patients with CDI only until symptom resolution (approximately 3-fold increase in isolation-days prevalence).
Even though our study focused on the quantitative impact of a CD carrier isolation program, the intervention also has a qualitative impact on the burden of isolation precautions. By the end of the study period, most isolation-days (~75%) were for CD carriers rather than for patients with CDI. Because isolation precautions for patients with CD carriage are qualitatively less burdensome (eg, no gowns are required and patients do not h require private rooms) [16] , the increase in the number of isolation-days is offset in part by the decrease in the complexity of the isolation measures. The optimal infection control measures against CDI are currently unknown, and recommendations have changed over the years as an attempt to control raising incidence rates, and due to improved understanding of the disease. In 2010, the CDI practice guidelines from the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA) recommended the maintenance of isolation precautions until resolution of diarrhea [22] , The 2014 updated SHEA/IDSA guidelines maintained this recommendation, but also recognized that some experts may prefer extending isolation precautions for at least 48 hours after symptom resolution, and acknowledged that isolation measures could be maintained until hospital discharge when CDI incidence remains higher than the institution's goal [7] . The European Centre for Disease Prevention and Control (ECDC) recommended in their 2008 guidelines that isolation precautions should be maintained until 48 hours after symptom resolution [8] . The optimal recommendation must also take into account local epidemiology. Some hospitals with low CDI incidence have not detected a significant increase in C. difficile transmission following discontinuation of isolation precautions for patients with CDI [23] .
Our study has strengths. To the best of our knowledge, it is the first to compare different CDI infection control strategies in terms of isolation burden. It addresses an urgent need and provides important insight into the logistical impact of a CD carrier isolation policy [18, 22, 24] . Although there are few studies regarding the isolation burden of C. difficile against which our results could be compared, a US acute-care hospital reported that CDI was responsible for a third of all isolation-days needs, only second to methicillin-resistant Staphylococcus aureus [25] . This suggests that CDI places a sizeable burden on hospital resources.
The study also has limitations. The intervention was performed in a single center that had high CDI incidence and that was endemic for the NAP1 strain. CD carriers were detected by PCR; although very sensitive, this method has been associated with false-positive results in other studies [26] . Whether these results could be generalizable to other settings remains to be determined. The short-and long-term impacts to changes in policies could vary between centers. Facilities that discontinue isolation precautions for CDI patients upon symptom resolution should expect a more significant increase in isolation burden following implementation. The study design does not allow for establishing a causal link between the changes in policy and the changes in isolation precaution burden. Further investigations-ultimately cluster randomized trials-will be required to confirm our findings. Some important factors such as costs or the impact on caregiver compliance, quality of care, and patient satisfaction could not be investigated [27] [28] [29] [30] .
In conclusion, in a single center, the implementation of a strategy detecting and isolation CD carriers led to an initial increase in isolation burden; this increase was offset in part by a decrease in isolation needs for CDI.
Notes
